Platelet-activating factor increases platelet-dependent glycoconjugate secretion from tracheal submucosal gland

Area of Science:

• Respiratory Physiology
• Immunology
• Pharmacology

Background:

• Airway mucus secretion is crucial for respiratory health.
• Platelet-activating factor (PAF) is implicated in inflammatory responses.
• The role of platelets in PAF-mediated airway secretion requires clarification.

Purpose of the Study:

• To investigate the effect of PAF on glycoconjugate release and glandular contraction in isolated feline tracheal glands.
• To determine the role of platelets and their functional products in PAF-induced airway secretion.

Main Methods:

• Isolated feline tracheal glands were used to measure radiolabeled glycoconjugate release and glandular contraction.
• Experiments were conducted in the absence and presence of purified platelets.
• PAF concentrations, time-dependency, and the effects of antagonists (CV-3988, methysergide, indomethacin, SQ 29,548) were assessed.

Main Results:

• PAF alone did not induce significant glandular contraction or glycoconjugate release.
• In the presence of platelets, PAF caused a dose- and time-dependent increase in glycoconjugate secretion.
• PAF-evoked secretion was inhibited by a PAF antagonist and thromboxane synthesis/receptor antagonists, but not by a 5-HT antagonist.
• Thromboxane A2 analogue mimicked the secretory effect of PAF.

Conclusions:

• PAF potentiates glycoconjugate release from feline tracheal glands specifically in the presence of platelets.
• The secretory response to PAF is mediated by platelet-derived thromboxane generation.
• These findings highlight a novel mechanism involving platelet-thromboxane in regulating airway mucus secretion.